Electronic ISSN 2287-0237



  1. World Health Organization. Atlas of headache disorders and resources in the world 2011: A collaborative project of World Health Organization and Lifting the Burden. Geneva: World Health Organisation; 2011.
  2. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27(3):193-210.
  3. Bloudek LM, Stokes M, Buse DC, et al. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain 2012;13(5):361-78.
  4. Stokes M, Becker WJ, Lipton RB, et al. Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS). Headache 2011;51(7):1058-77.
  5. Headache Classification Committee of the International Headache Society (HIS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33(9):629-808.
  6. Lipton RB, Buse DC, Saiers J, et al. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. J Med Econ 2013;16(4):490-9.
  7. DALYs GBD, Collaborators H, Murray CJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 2015;386(10009):2145-91.
  8. Steiner TJ, Birbeck GL, Jensen RH, et al. Headache disorders are third cause of disability worldwide. J Headache Pain 2015;16:58.
  9. Lipton RB, Bigal M, Diamond M. Migraine prevalence, disease burden and the need for preventive therapy. Neurology 2007;68:343-9.
  10. Loder S, Sheikh HU, Loder E. The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey studies. Headache 2015;55(2):214-28.
  11. Lipton RB, Stewart WF, Sawyer J, et al. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache 2001;41(9):854-61.
  12. Stewart WF, Lipton RB, Dowson AJ, et al. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 2001;56(6 Suppl 1):S20-S8.
  13. Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003;12(8):963-74.
  14. Yang M, Rendas-Baum R, Varon SF, et al. Validation of the Headache Impact Test (HIT-6) across episodic and chronic migraine. Cephalalgia 2011;31(3):357-67.
  15. Dowson AJ. Assessing the impact of migraine. Curr Med Res Opin 2001;17:298-309.
  16. Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 1999;53(5):988-94.
  17. D'Amico D, Mosconi P, Genco S, et al. The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia 2001;21(10):947-52.18.Iigaya M, Sakai F, Kolodner KB, et al. Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire. Headache 2003;43(4):343-52.
  18. Ertas M, Siva A, Dalkara T, et al. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire. Headache 2004;44(8):786-93.
  19. Gedikoglu U, Coskun O, Inan LE, et al. Validity and reliability of Turkish translation of Migraine Disability Assessment (MIDAS) questionnaire in patients with migraine. Cephalalgia 2005;25(6):452-6.
  20. Magnoux E, Freeman MA, Zlotnik G. MIDAS and HIT-6 French translation: reliability and correlation between tests. Cephalalgia 2008;28(1):26-34.
  21. Zandifar A, Asgari F, Haghdoost F, et al. Reliability and validity of the migraine disability assessment scale among migraine and tension type headache in Iranian patients. Biomed Res Int 2014;2014:978064.
  22. Shaik MM, Hassan NB, Tan HL, et al. Validity and reliability of the Bahasa Melayu version of the Migraine Disability Assessment questionnaire. Biomed Res Int 2014;2014:435856.
  23. Ramsey S, Willke R, Briggs A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health 2005;8(5):521-33.
  24. Hinkle DE, Wiersma W, Jurs SG. Applied Statistics for the Behavioral Sciences. 5th ed. Boston: Houghton Mifflin; 2003.
  25. Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med 2016;15(2):155-63.)
  26. Seethong P, Nimmannit A, Chaisewikul R, et al. Reliability and Validity of Migraine Disability Assessment Questionnaire-Thai Version (Thai-MIDAS). J Med Assoc Thai 2013;96 Suppl 2:S29-38.